The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer

[1]  M. Yun,et al.  18Fluoro‐deoxy‐glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer , 2011, Journal of surgical oncology.

[2]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[3]  M. Joyce,et al.  Surgical Management of Locally Recurrent Rectal Cancer , 2012, International journal of surgical oncology.

[4]  K. Koda,et al.  Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer , 1999, The British journal of surgery.

[5]  P Schmidlin,et al.  Recurrence of colorectal tumors: PET evaluation. , 1989, Radiology.

[6]  J. Petiot,et al.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.

[7]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[8]  E. Hughes,et al.  Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients , 1985, The British journal of surgery.

[9]  Y. Doki,et al.  The features of late local recurrences following curative surgery for rectal cancer. , 2012, Hepato-gastroenterology.

[10]  T. Kato,et al.  Recurrent rectal cancer and scar: differentiation with PET and MR imaging. , 1992, Radiology.

[11]  Wolfgang A Weber,et al.  Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Y. Doki,et al.  Clinicopathological Assessment of Locally Recurrent Rectal Cancer and Relation to Local Re-Recurrence , 2011, Annals of Surgical Oncology.

[13]  G. Beets,et al.  MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer , 2014, Nature Reviews Gastroenterology &Hepatology.

[14]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[15]  Hiroyuki Yamada,et al.  Diagnostic value of 18F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma , 2014, Surgery Today.

[16]  S. Andreola,et al.  Surgical treatment of locally recurrent rectal carcinoma , 1997, Diseases of the colon and rectum.

[17]  P. Sagar,et al.  Surgical management of locally recurrent rectal cancer , 1996, The British journal of surgery.

[18]  Wolfgang A Weber,et al.  PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. , 2007, The Lancet. Oncology.

[19]  H. Groen,et al.  18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  PhD Facs Masaki Mori MD,et al.  Prevention of Severe Pelvic Abscess Formation Following Extended Radical Surgery for Locally Recurrent Rectal Cancer , 2009, Annals of Surgical Oncology.

[21]  M. Schwaiger,et al.  Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography , 2001, Annals of surgery.

[22]  J. Scholefield,et al.  Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[23]  H. Ishii,et al.  Prevention of Severe Pelvic Abscess Formation Following Extended Radical Surgery for Locally Recurrent Rectal Cancer , 2009, Annals of surgical oncology.

[24]  Johan Bussink,et al.  PET-CT for response assessment and treatment adaptation in head and neck cancer. , 2010, The Lancet. Oncology.

[25]  M. Marzola,et al.  Early prediction of response by ¹⁸F-FDG PET/CT during preoperative therapy in locally advanced rectal cancer: a systematic review. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  U. Patel,et al.  Rectal cancer: primary staging and assessment after chemoradiotherapy. , 2011, Seminars in radiation oncology.

[27]  Y. Sakamoto,et al.  Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer , 2015, Surgery Today.

[28]  R. Pai,et al.  Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer , 2012, American journal of clinical oncology.